To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene FGFR2TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
392 supporting clones for gene FGFR2 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_022970.3   .a 1 to 4642 1 to 4642 exact RefSeq, AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 4642/4642
(100 %)
0 diff
(100 %id)
M97193 placenta .a 56 to 3116 19 to 3080 exact tiling clone,   3062/3080
(99 %)
7 diff
(99.8 %id)
AB030073   .a 223 to 2955 1 to 2726   tiling clone,   2726/2941
(92 %)
12 diff
(99.6 %id)
AB030074   .a 223 to 2951 1 to 2722       2722/2876
(94 %)
10 diff
(99.7 %id)
AB030075   .a 223 to 2956 1 to 2727       2727/3071
(88 %)
11 diff
(99.7 %id)
AB030076   .a 223 to 2951 1 to 2722       2722/2868
(94 %)
10 diff
(99.7 %id)
AB030077   .a 223 to 2951 1 to 2722       2722/2923
(93 %)
10 diff
(99.7 %id)
AB030078   .a 223 to 2956 1 to 2727       2727/2826
(96 %)
12 diff
(99.6 %id)
M80634 mammary gland .a 223 to 3335 1 to 3106 G633R tiling clone,   3106/3106
(100 %)
9 diff
(99.8 %id)
BE932236 head_neck .a 1368 to 1809 1 to 442       442/442
(100 %)
0 diff
(100 %id)
CN402795 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1442 to 2055 1 to 615       615/615
(100 %)
1 diff
(99.9 %id)
AI670114 thymus, pooled .a 1585 to 2163 579 to 1       579/580
(99 %)
7 diff
(98.8 %id)
BF879880 lung_tumor .a 1772 to 2192 420 to 1     Submitted on the opposite strand 419/420
(99 %)
12 diff
(97.2 %id)
AU132307   .a 1812 to 2609 2 to 800   capped   799/802
(99 %)
5 diff
(99.4 %id)
BM792391 Ascites, stomach .a 1831 to 2524 1 to 693       693/693
(100 %)
1 diff
(99.9 %id)
AU153854   .a 4005 to 4564 561 to 1   tiling clone,   561/561
(100 %)
10 diff
(98.3 %id)
NM_000141.4   .b 1 to 4639 1 to 4639 exact RefSeq, AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 4639/4639
(100 %)
0 diff
(100 %id)
M87770 brain .b 375 to 4628 1 to 4252 exact tiling clone, AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 4252/4252
(100 %)
5 diff
(99.9 %id)
X52832 brainstem .b 467 to 3883 1 to 3415 exact     3415/3415
(100 %)
6 diff
(99.9 %id)
Z71929 blood .b 636 to 3883 1 to 3248   tiling clone,   3248/3248
(100 %)
2 diff
(100.0 %id)
CN345548 embryonic stem cells, cell lines H1, H7, andH9 .b 995 to 1714 1 to 720       720/720
(100 %)
3 diff
(99.6 %id)
CN345540 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 1017 to 1642 5 to 630       626/630
(99 %)
4 diff
(99.4 %id)
CN345538 embryonic stem cells, cell lines H1, H7, andH9 .b 1367 to 2040 1 to 675       675/675
(100 %)
1 diff
(99.9 %id)
DA112545 cerebellum .b 1441 to 1991 2 to 553   capped   552/553
(99 %)
2 diff
(99.7 %id)
DA725048   .b 1599 to 2164 2 to 567   capped   566/566
(100 %)
3 diff
(99.5 %id)
CX752372 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 1692 to 2430 34 to 772     Submitted on the opposite strand 739/772
(95 %)
6 diff
(99.3 %id)
M55614   .c 1 to 2472 1 to 2481 A318V A319L G320K V321A N322A ... tiling clone,   2481/2481
(100 %)
3 diff
(99.9 %id)
NM_001144913.1   .d 1 to 2781 1 to 2781 exact RefSeq,   2781/2781
(100 %)
0 diff
(100 %id)
X56191 gastric cancer .d 127 to 2776 1 to 2650   tiling clone,   2650/2650
(100 %)
5 diff
(99.9 %id)
NM_001144914.1   .e 1 to 3806 1 to 3806 exact RefSeq, AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 3806/3806
(100 %)
0 diff
(100 %id)
AB084153   .e 151 to 2280 1 to 2130   tiling clone,   2130/2130
(100 %)
1 diff
(100.0 %id)
AK294026 cerebellum .f 1 to 3106 2 to 3105 L176P K240N tiling clone,   3105/3105
(100 %)
5 diff
(99.9 %id)
NM_001144915.1   .f 1 to 3692 2 to 3693 exact RefSeq, AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 3693/3693
(100 %)
0 diff
(100 %id)
DA124984 cerebellum .f 1 to 560 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
CK001244 brain/CNS, Bulk tissue from Human Spinal cord .g 1 to 619 1 to 619   tiling clone,   619/619
(100 %)
3 diff
(99.6 %id)
AK308621 cerebellum .g 348 to 3342 1 to 2995 K305R tiling clone,   2995/2995
(100 %)
2 diff
(100.0 %id)
NM_001144916.1   .g 348 to 4435 1 to 4088 exact RefSeq, AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 4088/4088
(100 %)
0 diff
(100 %id)
DA103039 cerebellum .g 349 to 931 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
NM_001144917.1   .h 1 to 4291 1 to 4291 exact RefSeq, AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 4291/4291
(100 %)
0 diff
(100 %id)
CN345547 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .h 123 to 816 1 to 694   tiling clone,   694/694
(100 %)
1 diff
(99.9 %id)
M87771   .h 161 to 3404 1 to 3244 exact tiling clone,   3244/3244
(100 %)
3 diff
(100.0 %id)
DR005724 Prostate .h 334 to 946 1 to 612       612/612
(100 %)
7 diff
(98.9 %id)
DN993711 brain, whole brain .h 348 to 1037 8 to 697       690/697
(98 %)
6 diff
(99.2 %id)
DR001520 fetal brain .h 399 to 1102 1 to 704       704/720
(97 %)
8 diff
(98.9 %id)
DR002343 fetal brain .h 441 to 1161 9 to 729       721/729
(98 %)
6 diff
(99.2 %id)
DN990069 brain, whole brain .h 446 to 867 8 to 429       422/429
(98 %)
6 diff
(98.7 %id)
BF945721 nervous_normal .h 456 to 805 36 to 385       350/438
(79 %)
11 diff
(97.5 %id)
CD655828 Embryonic Stem cells .h 577 to 1159 12 to 594       583/788
(73 %)
23 diff
(97.1 %id)
DA191363 amygdala .h 667 to 1266 2 to 601   capped   600/600
(100 %)
0 diff
(100 %id)
CD631730   .h 740 to 1267 1 to 525       525/525
(100 %)
3 diff
(99.5 %id)
CD631728   .h 755 to 1267 17 to 532       519/532
(97 %)
15 diff
(97.2 %id)
CD631729   .h 755 to 1266 512 to 1       512/527
(97 %)
2 diff
(99.7 %id)
CD631731   .h 755 to 1266 511 to 1       511/526
(97 %)
2 diff
(99.7 %id)
CD631726   .h 782 to 1267 1 to 486       486/486
(100 %)
4 diff
(99.2 %id)
CD631727   .h 782 to 1266 485 to 1       485/485
(100 %)
3 diff
(99.4 %id)
AA548551 germ cell tumor .h 801 to 1100 297 to 1       297/324
(91 %)
17 diff
(94.8 %id)
AI498743 anaplastic oligodendroglioma, brain .h 819 to 1100 282 to 1       282/282
(100 %)
12 diff
(95.8 %id)
BQ344950 nervous_tumor .h 906 to 1154 254 to 3       250/254
(98 %)
7 diff
(97.3 %id)
BX494234 Liver .h 909 to 1432 1 to 525       525/525
(100 %)
2 diff
(99.7 %id)
DN917946   .h 923 to 1567 1 to 640       640/654
(97 %)
9 diff
(98.7 %id)
BM753450 Ascites, stomach .h 1064 to 1574 1 to 511       511/511
(100 %)
2 diff
(99.7 %id)
BI818207 pooled brain, lung, testis .i 1 to 280 1 to 282   tiling clone,   282/282
(100 %)
7 diff
(97.6 %id)
BI457785 brain, hypothalamus .i 201 to 720 1 to 530       530/743
(71 %)
22 diff
(97.1 %id)
BC039243 Brain, hypothalamus .i 206 to 3748 1 to 3543 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 3543/3543
(100 %)
4 diff
(99.9 %id)
NM_001144918.1   .i 206 to 4493 1 to 4288 exact RefSeq, AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 4288/4288
(100 %)
0 diff
(100 %id)
DB496217 hypothalamus .i 209 to 653 1 to 445       445/446
(99 %)
2 diff
(99.6 %id)
DB502258 hypothalamus .i 216 to 677 1 to 462       462/462
(100 %)
1 diff
(99.8 %id)
DR002646 fetal brain .i 222 to 821 1 to 603       603/603
(100 %)
9 diff
(98.6 %id)
DR002961 fetal brain .i 233 to 948 1 to 717       717/717
(100 %)
8 diff
(98.9 %id)
CN345541 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .i 234 to 616 1 to 384       384/393
(97 %)
4 diff
(99.0 %id)
TI_44170636   .i 242 to 906 83 to 767       569/776
(73 %)
12 diff
(98.5 %id)
DR005610 Prostate .i 243 to 953 1 to 711       711/711
(100 %)
8 diff
(98.9 %id)
BI553943 brain, hippocampus .i 246 to 905 1 to 680       679/690
(98 %)
26 diff
(96.3 %id)
CN345546 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .i 248 to 824 1 to 578       578/582
(99 %)
5 diff
(99.2 %id)
DB474000 hippocampus .i 251 to 702 1 to 452       452/487
(92 %)
9 diff
(98.2 %id)
DR006184 Prostate .i 252 to 938 7 to 692       686/692
(99 %)
9 diff
(98.7 %id)
CN345542 embryonic stem cells, cell lines H1, H7, andH9 .i 262 to 557 1 to 296       296/296
(100 %)
0 diff
(100 %id)
BX378997 Placenta Cot 25-normalized .i 281 to 600 320 to 1     Submitted on the opposite strand 320/336
(95 %)
3 diff
(99.2 %id)
AI092260 parathyroid gland, parathyroid tumor .i 281 to 817 1 to 537     Submitted on the opposite strand 537/537
(100 %)
4 diff
(99.3 %id)
AI143675 anaplastic oligodendroglioma, brain .i 281 to 806 1 to 526     Submitted on the opposite strand 526/526
(100 %)
6 diff
(98.9 %id)
AI500404 anaplastic oligodendroglioma, brain .i 281 to 839 1 to 554     Submitted on the opposite strand 554/554
(100 %)
17 diff
(97.0 %id)
AI807481 pooled .i 281 to 961 1 to 679     Submitted on the opposite strand 679/680
(99 %)
14 diff
(98.0 %id)
BE348962 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .i 281 to 735 1 to 456     Submitted on the opposite strand 456/456
(100 %)
12 diff
(97.4 %id)
BF739773 brain, oligodendroglioma .i 281 to 903 1 to 622     Submitted on the opposite strand 622/625
(99 %)
4 diff
(99.4 %id)
BF431511 Kidney .i 281 to 649 1 to 369     Submitted on the opposite strand 369/369
(100 %)
1 diff
(99.8 %id)
AA772398 parathyroid gland, parathyroid tumor .i 282 to 878 1 to 586     Submitted on the opposite strand 586/586
(100 %)
26 diff
(95.6 %id)
AA772399 parathyroid gland, parathyroid tumor .i 282 to 815 1 to 521     Submitted on the opposite strand 521/521
(100 %)
29 diff
(94.5 %id)
DR002573 fetal brain .i 284 to 922 1 to 641       641/641
(100 %)
9 diff
(98.6 %id)
CN345549 embryonic stem cells, cell lines H1, H7, andH9 .i 299 to 856 1 to 558       558/558
(100 %)
1 diff
(99.9 %id)
AI368565 anaplastic oligodendroglioma, brain .i 299 to 716 1 to 415     Submitted on the opposite strand 415/452
(91 %)
21 diff
(95.4 %id)
AI083781 anaplastic oligodendroglioma, brain .i 300 to 774 1 to 475     Submitted on the opposite strand 475/475
(100 %)
3 diff
(99.4 %id)
AI379172 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i 300 to 806 1 to 507   tiling clone, Submitted on the opposite strand 507/507
(100 %)
29 diff
(94.3 %id)
DN996657 breast cancer, Mammary gland (cancer tissue) .i 300 to 952 1 to 653       653/653
(100 %)
5 diff
(99.3 %id)
AI871363 anaplastic oligodendroglioma, brain .i 303 to 937 1 to 633     Submitted on the opposite strand 633/633
(100 %)
9 diff
(98.6 %id)
AL708538 human skeletal muscle .i 451 to 961 1 to 511       511/512
(99 %)
1 diff
(99.9 %id)
DR006288 Prostate .i 471 to 909 1 to 439       439/439
(100 %)
1 diff
(99.8 %id)
AA843793 parathyroid gland, parathyroid tumor .i 522 to 959 18 to 452     Submitted on the opposite strand 435/458
(94 %)
44 diff
(90.4 %id)
DN992091 brain, whole brain .i 535 to 1077 1 to 541   tiling clone,   541/541
(100 %)
6 diff
(98.9 %id)
CD674163 eye, lens .i 551 to 827 1 to 277       277/277
(100 %)
1 diff
(99.7 %id)
BF918554 nervous_tumor .i 593 to 961 17 to 385       369/397
(92 %)
7 diff
(98.3 %id)
BM853743 Ascites, stomach .i 977 to 1282 1 to 308       308/308
(100 %)
4 diff
(98.8 %id)
CA392614 eye, RPE/choroid .i 999 to 1655 1 to 657       657/657
(100 %)
2 diff
(99.7 %id)
CX873387 embryonic stem .i 1097 to 1834 1 to 737   tiling clone,   737/737
(100 %)
1 diff
(99.9 %id)
CN345539 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .i 1142 to 1794 1 to 653       653/653
(100 %)
2 diff
(99.7 %id)
CN345553 embryonic stem cells, cell lines H1, H7, andH9 .i 1228 to 1867 25 to 664       640/664
(96 %)
6 diff
(99.1 %id)
DA111274 cerebellum .i 1500 to 2044 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA296724 hippocampus .i 1646 to 2224 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
CN345543 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .i 1662 to 2386 1 to 726       726/726
(100 %)
4 diff
(99.5 %id)
CN345551 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .i 1665 to 2127 1 to 463       463/463
(100 %)
2 diff
(99.6 %id)
T28903 brain .i 1801 to 2248 448 to 1     Submitted on the opposite strand 448/448
(100 %)
6 diff
(98.7 %id)
CD643272 Embryonic Stem cells .i 1837 to 2590 2 to 755       754/757
(99 %)
10 diff
(98.7 %id)
BI088763 cervix .i 1871 to 2419 1 to 551       551/621
(88 %)
11 diff
(98.3 %id)
CD675167 eye, lens .i 1885 to 2564 1 to 680       680/680
(100 %)
0 diff
(100 %id)
CD675382 eye, lens .i 1885 to 2488 1 to 604       604/606
(99 %)
9 diff
(98.6 %id)
BX499228 Liver .i 1898 to 2277 1 to 380       380/380
(100 %)
0 diff
(100 %id)
CB217005 normal endometrium, mid-secretory phase,cycle day 23, uterus .i 1956 to 2677 1 to 722       722/722
(100 %)
1 diff
(99.9 %id)
BM854804 Ascites, stomach .i 1984 to 2531 1 to 548       548/548
(100 %)
0 diff
(100 %id)
BG984043 colon_normal .i 2054 to 2329 338 to 63       276/338
(81 %)
0 diff
(100 %id)
CD103439 Pooled-Skin .i 2134 to 2812 1 to 690       690/752
(91 %)
19 diff
(97.5 %id)
CN402796 embryonic stem cells, DMSO-treated H9 cellline .i 2144 to 2761 1 to 618       618/621
(99 %)
1 diff
(99.9 %id)
BG426972 Kidney .i 2194 to 2971 1 to 772       772/772
(100 %)
23 diff
(97.1 %id)
BE162251 head_neck .i 2281 to 2596 1 to 316       316/316
(100 %)
5 diff
(98.5 %id)
DA179540 amygdala .i 2308 to 2861 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
BQ438964 epithelioid carcinoma, Pancreas .i 2388 to 3265 1 to 881       881/885
(99 %)
6 diff
(99.4 %id)
BG698600 skin .i 2401 to 3211 21 to 834       814/834
(97 %)
21 diff
(97.5 %id)
F05643 brain, total brain .i 2422 to 2685 1 to 265       265/265
(100 %)
1 diff
(99.7 %id)
R13671 whole brain .i 2423 to 2698 1 to 277       277/363
(76 %)
6 diff
(98.4 %id)
BF768911 epid_tumor .i 2433 to 2845 1 to 413       413/413
(100 %)
9 diff
(97.9 %id)
CX758275 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .i 2456 to 3147 1 to 692     Submitted on the opposite strand 692/692
(100 %)
0 diff
(100 %id)
BF886335 testis_normal .i 2457 to 2970 14 to 529       516/529
(97 %)
13 diff
(97.6 %id)
CD703452 normal nasopharynx .i 2536 to 3085 37 to 588       552/588
(93 %)
9 diff
(98.5 %id)
BI001128 head_normal .i 2541 to 2801 259 to 1       259/259
(100 %)
9 diff
(96.6 %id)
AV722834 hypothalamus .i 2573 to 3242 16 to 679       664/694
(95 %)
21 diff
(97.0 %id)
AV721924 hypothalamus .i 2574 to 3007 1 to 427       427/430
(99 %)
7 diff
(98.4 %id)
AI127918 uterus .i 2577 to 3403 833 to 4       830/833
(99 %)
7 diff
(99.2 %id)
CB986038 Pooled-Glandular .i 2604 to 3151 1 to 560   AAA   560/568
(98 %)
29 diff
(94.9 %id)
CN345544 embryonic stem cells, DMSO-treated H9 cellline .i 2624 to 3239 1 to 616       616/616
(100 %)
0 diff
(100 %id)
BX499469 Liver .i 2631 to 3001 1 to 371       371/371
(100 %)
2 diff
(99.5 %id)
BM788828 Ascites, stomach .i 2651 to 3231 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BM793028 Ascites, stomach .i 2651 to 3285 1 to 635       635/635
(100 %)
1 diff
(99.9 %id)
T84335 liver and spleen .i 2656 to 3007 1 to 358       358/414
(86 %)
8 diff
(98.1 %id)
CB243667 Human Lung Epithelial cells, lung .i 2672 to 3451 796 to 17   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 780/781
(99 %)
0 diff
(100 %id)
TI_153990512   .i 2697 to 3399 782 to 90   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 693/878
(78 %)
16 diff
(98.2 %id)
BE927092 breast .i 2703 to 2921 236 to 21       216/248
(87 %)
2 diff
(99.2 %id)
BF059273 pooled germ cell tumors .i 2710 to 3400 693 to 2       692/693
(99 %)
6 diff
(99.2 %id)
CN345537 embryonic stem cells, cell lines H1, H7, andH9 .i 2727 to 3034 1 to 307       307/307
(100 %)
1 diff
(99.7 %id)
H83199 liver and spleen .i 2749 to 3087 1 to 343       343/349
(98 %)
6 diff
(98.3 %id)
BM826575 Ascites, stomach .i 2772 to 3399 1 to 628       628/628
(100 %)
1 diff
(99.9 %id)
R38513 whole brain .i 3318 to 3610 296 to 3       294/296
(99 %)
0 diff
(100 %id)
T89263 liver and spleen .i 3370 to 3535 167 to 1       167/167
(100 %)
1 diff
(99.5 %id)
F01900 brain, total brain .i 3385 to 3599 214 to 1       214/214
(100 %)
1 diff
(99.6 %id)
H82967 liver and spleen .i 4062 to 4449 414 to 11   tiling clone,   404/419
(96 %)
0 diff
(100 %id)
M35718   .j 1 to 2605 1 to 2605   tiling clone,   2605/3025
(86 %)
7 diff
(99.8 %id)
S41878   .j 2590 to 2899 1 to 310   tiling clone,   310/310
(100 %)
0 diff
(100 %id)
NM_001144919.1   .k 1 to 3011 1 to 3011 exact RefSeq,   3011/3011
(100 %)
0 diff
(100 %id)
AK026508   .k 27 to 3007 1 to 2981 exact tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 2981/2981
(100 %)
5 diff
(99.9 %id)
DR005770 Prostate .k 406 to 835 1 to 430       430/446
(96 %)
4 diff
(99.2 %id)
BM796114 Ascites, stomach .k 2304 to 2728 1 to 425       425/425
(100 %)
0 diff
(100 %id)
BC037338 Brain, hippocampus .l 1 to 3989 1 to 3989 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 3989/3989
(100 %)
7 diff
(99.9 %id)
TI_44170729   .l 1 to 668 130 to 798       669/798
(83 %)
16 diff
(98.0 %id)
DB542793 hippocampus .l 2680 to 3134 1 to 455     Submitted on the opposite strand 455/455
(100 %)
1 diff
(99.8 %id)
AI703144 carcinoid, lung .l 2688 to 3134 458 to 12   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 447/447
(100 %)
1 diff
(99.8 %id)
AI284647 ovary, tumor, 5 pooled (see description) .l 2691 to 3132 438 to 1       438/446
(98 %)
8 diff
(98.3 %id)
BG428365 Kidney .l 2695 to 3289 1 to 595       595/1006
(59 %)
8 diff
(99.3 %id)
TI_153949432   .l 2695 to 3469 77 to 862       786/1007
(78 %)
50 diff
(95.1 %id)
AA309031 colon .l 2696 to 3110 1 to 416       416/416
(100 %)
4 diff
(99.1 %id)
AA309032 colon .l 2696 to 3054 1 to 360       360/360
(100 %)
2 diff
(99.5 %id)
AW949426   .l 2697 to 3309 1 to 616       616/617
(99 %)
25 diff
(96.0 %id)
AW949428   .l 2697 to 3308 1 to 612       612/612
(100 %)
1 diff
(99.9 %id)
BM825786 Ascites, stomach .l 2705 to 3031 1 to 327       327/327
(100 %)
1 diff
(99.7 %id)
BI092661 cervix .l 2711 to 3503 1 to 780       780/786
(99 %)
13 diff
(98.4 %id)
AI638387 pooled germ cell tumors .l 2724 to 2930 208 to 2       207/208
(99 %)
0 diff
(100 %id)
AI638356 pooled germ cell tumors .l 2725 to 2929 205 to 1       205/205
(100 %)
0 diff
(100 %id)
BG706936 brain, hypothalamus .l 2726 to 3396 1 to 673       673/673
(100 %)
9 diff
(98.7 %id)
BX098727 whole brain .l 2734 to 3134 415 to 15   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 401/404
(99 %)
1 diff
(99.8 %id)
EL952680 eyeball .l 2736 to 3129 19 to 411   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 393/411
(95 %)
8 diff
(98.1 %id)
BI035787 nervous_tumor .l 2737 to 3125 1 to 389       389/389
(100 %)
0 diff
(100 %id)
CX782155 human embryonic stem cells .l 2789 to 3556 1 to 768   fully sequenced, Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 768/768
(100 %)
0 diff
(100 %id)
AV681532 hepatocellular carcinoma .l 2820 to 3452 1 to 634       634/663
(95 %)
17 diff
(97.5 %id)
AV726725 hypothalamus .l 2857 to 3570 1 to 712       712/712
(100 %)
16 diff
(97.8 %id)
BM700099 eye, lens .l 2944 to 3527 1 to 584   fully sequenced,   584/584
(100 %)
0 diff
(100 %id)
H87979 cochlea, ear .l 2957 to 3123 1 to 167       167/167
(100 %)
0 diff
(100 %id)
BM797325 Ascites, stomach .l 3001 to 3491 1 to 491       491/491
(100 %)
0 diff
(100 %id)
EL946814 eyeball .l 3010 to 3535 1 to 526       526/526
(100 %)
9 diff
(98.3 %id)
R70205 breast .l 3052 to 3450 1 to 402       402/402
(100 %)
4 diff
(99.1 %id)
AA664355   .l 3057 to 3543 1 to 487     Submitted on the opposite strand 487/487
(100 %)
2 diff
(99.6 %id)
BM705646 eye, lens .l 3077 to 3449 1 to 373     Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 373/373
(100 %)
1 diff
(99.8 %id)
TI_149313439   .l 3107 to 3956 935 to 93   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 843/982
(85 %)
10 diff
(99.0 %id)
BU679390 lung, Primary Lung Epithelial Cells .l 3147 to 3659 1 to 518     Submitted on the opposite strand 518/526
(98 %)
7 diff
(98.7 %id)
TI_149289124   .l 3148 to 3989 944 to 109   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 836/976
(85 %)
20 diff
(98.0 %id)
AA235910.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .l 3156 to 3600 1 to 442     also hits gene N4BP2L2andN4BP2L1 442/442
(100 %)
15 diff
(96.7 %id)
BF769079 epid_tumor .l 3177 to 3606 482 to 53     Submitted on the opposite strand 430/482
(89 %)
0 diff
(100 %id)
BM706042 eye, lens .l 3195 to 3460 1 to 266       266/266
(100 %)
0 diff
(100 %id)
AA033657 uterus .l 3196 to 3603 1 to 408   fully sequenced,   408/408
(100 %)
0 diff
(100 %id)
AI436212 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .l 3197 to 3951 755 to 1       755/755
(100 %)
13 diff
(98.3 %id)
DV460466 cochlea, ear .l 3198 to 3454 7 to 263       257/267
(96 %)
4 diff
(98.6 %id)
CD675930 eye, lens .l 3211 to 3826 1 to 616       616/616
(100 %)
0 diff
(100 %id)
EB386309 eye, optic nerve .l 3219 to 3961 1 to 743       743/743
(100 %)
2 diff
(99.8 %id)
N50463 multiple sclerosis lesions .l 3220 to 3773 1 to 574       574/574
(100 %)
59 diff
(89.8 %id)
CB305354 lung, Primary Lung Cystic Fibrosis EpithelialCells .l 3242 to 3956 730 to 16   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 715/715
(100 %)
2 diff
(99.8 %id)
AI081876 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .l 3246 to 3991 747 to 1       747/747
(100 %)
12 diff
(98.4 %id)
AI433805 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .l 3271 to 4012 765 to 28   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 738/795
(92 %)
19 diff
(97.7 %id)
TI_154035986   .l 3273 to 4020 830 to 92   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 739/773
(95 %)
39 diff
(95.0 %id)
CA313204 Human Lung Epithelial cells, lung .l 3282 to 3881 1 to 599     Submitted on the opposite strand 599/600
(99 %)
6 diff
(99.0 %id)
TI_149313909   .l 3293 to 4023 827 to 98   tiling clone, AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 730/990
(73 %)
9 diff
(99.1 %id)
TI_149310187   .l 3294 to 3991 787 to 88   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 700/942
(74 %)
6 diff
(99.4 %id)
TI_154025745   .l 3299 to 3991 783 to 91   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 693/694
(99 %)
0 diff
(100 %id)
T94939 lung .l 3306 to 3534 1 to 233   fully sequenced,   233/233
(100 %)
8 diff
(96.6 %id)
AI559529 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .l 3312 to 4023 718 to 16   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 703/703
(100 %)
40 diff
(94.4 %id)
CA440010 lung, Metastatic Chondrosarcoma .l 3319 to 3991 689 to 17   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 673/673
(100 %)
0 diff
(100 %id)
AI421090 brain, glioblastoma (pooled) .l 3327 to 4013 685 to 3       683/735
(92 %)
0 diff
(100 %id)
BU688516 lung .l 3338 to 3991 670 to 17   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 654/654
(100 %)
0 diff
(100 %id)
BI491777 cochlea, ear .l 3343 to 3941 599 to 1       599/599
(100 %)
6 diff
(99.0 %id)
CA438509 lung, Metastatic Chondrosarcoma .l 3343 to 4020 696 to 19   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 678/678
(100 %)
1 diff
(99.9 %id)
BQ446665 Knee, Osteoarthritic Cartilage .l 3345 to 3991 663 to 17   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 647/647
(100 %)
0 diff
(100 %id)
CA428050 Bone, Subchondral Bone .l 3347 to 4020 692 to 19   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 674/674
(100 %)
0 diff
(100 %id)
BM992669 lung, Metastatic Chondrosarcoma .l 3351 to 3953 619 to 17   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 603/603
(100 %)
1 diff
(99.9 %id)
AA889062 pooled .l 3352 to 3994 642 to 1       642/642
(100 %)
29 diff
(95.5 %id)
AI887420 serous papillary carcinoma, high grade, 2pooled tumors, uterus .l 3357 to 3984 663 to 40   AAA   624/647
(96 %)
0 diff
(100 %id)
BE154202 head_neck .l 3363 to 3881 17 to 535       519/543
(95 %)
6 diff
(98.9 %id)
BF087036 head_neck .l 3363 to 3881 534 to 16       519/537
(96 %)
0 diff
(100 %id)
AA723410 heart .l 3366 to 3957 587 to 1       587/587
(100 %)
21 diff
(96.5 %id)
CB305736 lung, Primary Lung Cystic Fibrosis EpithelialCells .l 3375 to 4023 664 to 16   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 649/649
(100 %)
0 diff
(100 %id)
BE537575 cervix .l 3383 to 4012 1 to 633       633/636
(99 %)
8 diff
(98.8 %id)
BM745930 Ascites, stomach .l 3388 to 3900 1 to 513       513/513
(100 %)
3 diff
(99.5 %id)
AA236812.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .l 3389 to 3975 585 to 3     also hits gene ACTN2 583/585
(99 %)
0 diff
(100 %id)
FN149202 breast carcinoma .l 3393 to 3504 1 to 114       114/114
(100 %)
2 diff
(98.3 %id)
BE702299 nervous_normal .l 3405 to 3724 328 to 1       328/328
(100 %)
0 diff
(100 %id)
AI218552 pooled .l 3414 to 3991 577 to 1       577/577
(100 %)
9 diff
(98.5 %id)
BQ333743 marrow .l 3416 to 3708 294 to 3       292/295
(98 %)
0 diff
(100 %id)
AI264866   .l 3419 to 3974 567 to 19   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 549/549
(100 %)
16 diff
(97.1 %id)
AA424365 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .l 3431 to 3956 1 to 524   fully sequenced,   524/524
(100 %)
4 diff
(99.3 %id)
BF114612 pooled .l 3435 to 3955 522 to 2       521/522
(99 %)
0 diff
(100 %id)
AI290617 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .l 3437 to 4011 579 to 1       579/583
(99 %)
29 diff
(95.1 %id)
BU681584 lung .l 3437 to 3989 571 to 19   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 553/553
(100 %)
1 diff
(99.9 %id)
AW073347 brain, glioblastoma (pooled) .l 3440 to 4012 573 to 1       573/573
(100 %)
5 diff
(99.2 %id)
EL949024 eyeball .l 3446 to 3954 1 to 510       510/510
(100 %)
4 diff
(99.3 %id)
DV462265 cochlea, ear .l 3452 to 3821 374 to 3     Submitted on the opposite strand 372/374
(99 %)
0 diff
(100 %id)
AI142488 uterus .l 3458 to 3951 494 to 1       494/494
(100 %)
0 diff
(100 %id)
N55322 multiple sclerosis lesions .l 3460 to 3586 1 to 127       127/127
(100 %)
0 diff
(100 %id)
AI884363 serous papillary carcinoma, high grade, 2pooled tumors, uterus .l 3464 to 4022 560 to 2       559/560
(99 %)
0 diff
(100 %id)
BM662743 eye, RPE and Choroid .l 3464 to 3956 510 to 18   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 493/493
(100 %)
2 diff
(99.6 %id)
DV461870 cochlea, ear .l 3484 to 3815 1 to 332       332/332
(100 %)
8 diff
(97.6 %id)
AI336070 lung .l 3499 to 3986 488 to 1       488/488
(100 %)
12 diff
(97.6 %id)
BU734930 eye, lens .l 3502 to 4020 538 to 20   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 519/519
(100 %)
0 diff
(100 %id)
N67307 cochlea, ear .l 3503 to 3983 481 to 1       481/483
(99 %)
0 diff
(100 %id)
T94993 lung .l 3504 to 4012 505 to 1   fully sequenced,   505/505
(100 %)
4 diff
(99.3 %id)
AW514184 pooled .l 3505 to 4022 520 to 3       518/520
(99 %)
0 diff
(100 %id)
BU737898 eye, lens .l 3506 to 3979 487 to 14   fully sequenced,   474/487
(97 %)
0 diff
(100 %id)
AA724695 parathyroid gland, parathyroid tumor .l 3508 to 3993 487 to 2       486/487
(99 %)
0 diff
(100 %id)
AA608928   .l 3508 to 4013 513 to 2       512/513
(99 %)
0 diff
(100 %id)
AI379638 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .l 3511 to 4022 516 to 5       512/516
(99 %)
0 diff
(100 %id)
DB571955 hypothalamus .l 3519 to 3989 1 to 471     Submitted on the opposite strand 471/473
(99 %)
2 diff
(99.6 %id)
TI_149278901   .l 3519 to 4020 581 to 79   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 503/1159
(43 %)
4 diff
(99.7 %id)
BM969412 lung, Primary Lung Epithelial Cells .l 3519 to 4020 521 to 19   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 503/507
(99 %)
4 diff
(99.3 %id)
N95383 lung .l 3521 to 3956 430 to 1       430/517
(83 %)
6 diff
(98.9 %id)
CX782114 human embryonic stem cells .l 3526 to 3974 475 to 27   fully sequenced, AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 449/449
(100 %)
2 diff
(99.6 %id)
DB565627 hypothalamus .l 3532 to 3989 1 to 458     Submitted on the opposite strand 458/460
(99 %)
2 diff
(99.6 %id)
AA235346 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .l 3541 to 3974 434 to 1       434/434
(100 %)
2 diff
(99.6 %id)
AA687581 normal prostate, Prostate .l 3541 to 4012 472 to 1       472/472
(100 %)
11 diff
(97.7 %id)
AW628470 2 pooled high-grade transitional celltumors, genitourinary tract .l 3541 to 4020 491 to 12   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 480/480
(100 %)
6 diff
(98.8 %id)
AI073906 breast .l 3543 to 3993 451 to 1       451/451
(100 %)
0 diff
(100 %id)
DB547858 hippocampus .l 3546 to 3991 1 to 446     Submitted on the opposite strand 446/446
(100 %)
0 diff
(100 %id)
BE855923 brain, glioblastoma (pooled) .l 3546 to 4013 469 to 2       468/469
(99 %)
0 diff
(100 %id)
AI263602   .l 3552 to 4020 471 to 12   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 460/464
(99 %)
15 diff
(96.8 %id)
AI805693 serous papillary carcinoma, high grade, 2pooled tumors, uterus .l 3557 to 3991 431 to 1       431/431
(100 %)
16 diff
(96.3 %id)
BF590017 Kidney .l 3557 to 3956 400 to 1       400/400
(100 %)
2 diff
(99.5 %id)
AI869111 Prostate .l 3561 to 3994 436 to 1       436/436
(100 %)
17 diff
(96.2 %id)
AI423808 brain, glioblastoma (pooled) .l 3566 to 4013 447 to 2       446/447
(99 %)
0 diff
(100 %id)
AI076491   .l 3570 to 4023 467 to 14   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 454/454
(100 %)
4 diff
(99.2 %id)
AA032183 uterus .l 3573 to 3951 379 to 1   fully sequenced,   379/379
(100 %)
1 diff
(99.8 %id)
N66630 multiple sclerosis lesions .l 3579 to 4020 450 to 1       450/514
(87 %)
8 diff
(98.5 %id)
AA256191 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .l 3580 to 4012 1 to 432   fully sequenced, Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 432/432
(100 %)
4 diff
(99.1 %id)
AA776567   .l 3581 to 3912 336 to 1       336/340
(98 %)
11 diff
(96.8 %id)
CA444234 lung, Metastatic Chondrosarcoma .l 3591 to 4020 448 to 19   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 430/430
(100 %)
1 diff
(99.8 %id)
AA953586 Kidney, kidney tumor .l 3592 to 3954 363 to 1       363/363
(100 %)
0 diff
(100 %id)
AI140801 pooled .l 3605 to 4012 427 to 20   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 408/408
(100 %)
1 diff
(99.8 %id)
AI805484 serous papillary carcinoma, high grade, 2pooled tumors, uterus .l 3610 to 4021 409 to 1       409/409
(100 %)
8 diff
(98.1 %id)
AA984329 schizophrenic brain S-11 frontal lobe .l 3617 to 3992 375 to 1       375/375
(100 %)
1 diff
(99.8 %id)
CV421398 head_neck .l 3636 to 3861 1 to 225       225/229
(98 %)
17 diff
(92.6 %id)
AI263355 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .l 3642 to 3991 350 to 1       350/350
(100 %)
0 diff
(100 %id)
T29856 thyroid gland .l 3647 to 3961 343 to 24     Submitted on the opposite strand 320/398
(80 %)
0 diff
(100 %id)
D57474   .l 3650 to 4020 1 to 370       370/370
(100 %)
2 diff
(99.5 %id)
AW418776 pooled .l 3650 to 4022 375 to 3       373/375
(99 %)
0 diff
(100 %id)
CA436211 lung, Metastatic Chondrosarcoma .l 3654 to 4012 378 to 20   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 359/359
(100 %)
5 diff
(98.7 %id)
AI918460 serous papillary carcinoma, high grade, 2pooled tumors, uterus .l 3657 to 3991 336 to 1       336/336
(100 %)
14 diff
(95.9 %id)
CD677918 eye, Trabecular meshwork .l 3665 to 3989 1 to 325   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 325/325
(100 %)
3 diff
(99.1 %id)
AI683268 serous papillary carcinoma, high grade, 2pooled tumors, uterus .l 3700 to 3994 295 to 1       295/295
(100 %)
1 diff
(99.7 %id)
BU678633 lung, Primary Lung Epithelial Cells .l 3715 to 3945 249 to 19   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 231/231
(100 %)
0 diff
(100 %id)
AI042628 parathyroid gland, parathyroid tumor .l 3731 to 4024 302 to 8       295/320
(92 %)
0 diff
(100 %id)
AW196650 adenocarcinoma, Pancreas .l 3744 to 4013 273 to 4       270/273
(98 %)
0 diff
(100 %id)
AA424505 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .l 3760 to 3956 197 to 1   fully sequenced,   197/197
(100 %)
0 diff
(100 %id)
FN139005 breast carcinoma .l 3778 to 3881 1 to 102       102/102
(100 %)
2 diff
(98.1 %id)
DV459883 cochlea, ear .l 3816 to 3960 149 to 6     Submitted on the opposite strand 144/149
(96 %)
0 diff
(100 %id)
DV459968 cochlea, ear .l 3816 to 3960 150 to 7     Submitted on the opposite strand 144/150
(96 %)
0 diff
(100 %id)
AA256152 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .l 3837 to 4012 186 to 11   fully sequenced, AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 176/176
(100 %)
0 diff
(100 %id)
AI379298 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .l 3840 to 4022 185 to 3       183/287
(63 %)
0 diff
(100 %id)
N50410 multiple sclerosis lesions .l 3846 to 4010 165 to 1       165/165
(100 %)
1 diff
(99.4 %id)
C00195   .l 3892 to 4012 1 to 121       121/121
(100 %)
0 diff
(100 %id)
AI918567 serous papillary carcinoma, high grade, 2pooled tumors, uterus .l 3902 to 4013 115 to 4       112/115
(97 %)
0 diff
(100 %id)
BC096749 Brain, hippocampus .m 1 to 3503 1 to 3502 M501C P502L Y503T E504N P505H ... tiling clone, AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 3502/3502
(100 %)
9 diff
(99.8 %id)
DN917947   .m 802 to 1461 659 to 1   tiling clone,   659/662
(99 %)
5 diff
(99.3 %id)
EU826598   .n 1 to 1191 1 to 1191 M162T tiling clone,   1191/1191
(100 %)
2 diff
(99.9 %id)
U11814 breast and cornea .o 1 to 1478 1 to 1475 exact tiling clone,   1475/1475
(100 %)
4 diff
(99.8 %id)
EU826599   .p 1 to 954 1 to 954 exact tiling clone,   954/954
(100 %)
1 diff
(99.9 %id)
EU826601   .q 1 to 846 1 to 846 T31I tiling clone,   846/846
(100 %)
4 diff
(99.6 %id)
M87772   .r 1 to 1473 1 to 1473 exact tiling clone,   1473/1541
(95 %)
6 diff
(99.7 %id)
BG005229 placenta_normal .r 1282 to 1675 10 to 406   tiling clone,   397/406
(97 %)
6 diff
(98.6 %id)
EU826600   .s 1 to 801 1 to 801 F252S tiling clone,   801/801
(100 %)
2 diff
(99.8 %id)
BM792927 Ascites, stomach .t 1 to 528 1 to 528 A100G tiling clone,   528/528
(100 %)
1 diff
(99.9 %id)
EB386117 eye, optic nerve .u 1 to 579 593 to 15 T14P A34V N64T D96A N129T tiling clone, AAA Submitted on the opposite strand 579/593
(97 %)
6 diff
(99.0 %id)
AI500276 anaplastic oligodendroglioma, brain .u 55 to 579 526 to 2       525/597
(87 %)
6 diff
(99.0 %id)
AI188214   .u 57 to 579 532 to 10   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 523/532
(98 %)
0 diff
(100 %id)
BE504886 pooled germ cell tumors .u 63 to 582 520 to 1   tiling clone,   520/520
(100 %)
3 diff
(99.5 %id)
AA975393 leiomyosarcoma, soft tissue .u 76 to 544 464 to 1       464/468
(99 %)
8 diff
(98.3 %id)
AA975827 carcinoid, lung .u 89 to 578 486 to 1       486/486
(100 %)
6 diff
(98.8 %id)
DB573463 hypothalamus .u 107 to 578 1 to 472     Submitted on the opposite strand 472/472
(100 %)
0 diff
(100 %id)
DB537363 hippocampus .u 173 to 578 1 to 407     Submitted on the opposite strand 407/408
(99 %)
18 diff
(95.6 %id)
AA293228 ovarian tumor, ovary .u 185 to 577 393 to 1     Submitted on the opposite strand 393/395
(99 %)
2 diff
(99.5 %id)
AI801468 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .va-u 1 to 434 449 to 16 E34K tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 434/449
(96 %)
0 diff
(100 %id)
AW451564   .va-u 17 to 432 432 to 17   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 416/436
(95 %)
0 diff
(100 %id)
AW451446   .va-u 17 to 432 432 to 17   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 416/442
(94 %)
0 diff
(100 %id)
BF002774 Prostate .va-u 50 to 432 382 to 1       382/382
(100 %)
1 diff
(99.8 %id)
AI493472 anaplastic oligodendroglioma, brain .vb 1 to 434 464 to 31 T10P R12K F48S S49V L50* tiling clone, AAA   434/434
(100 %)
15 diff
(96.6 %id)
BM824369 Ascites, stomach .vc 1 to 497 1 to 497 exact tiling clone,   497/497
(100 %)
3 diff
(99.4 %id)
AA456160 ovarian tumor, ovary .vd-u 1 to 468 1 to 467 exact tiling clone,   467/467
(100 %)
2 diff
(99.6 %id)
AV660593 corresponding non cancerous liver tissue .vd-u 145 to 563 1 to 419   tiling clone, Submitted on the opposite strand 419/419
(100 %)
1 diff
(99.8 %id)
TI_153957649   .vd-u 182 to 992 79 to 885   tiling clone, fully sequenced, Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 807/807
(100 %)
44 diff
(94.6 %id)
BG675189 skin .vd-u 521 to 1419 1 to 902   tiling clone,   902/906
(99 %)
36 diff
(96.1 %id)
TI_149287981   .vd-u 763 to 1632 947 to 94   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 854/956
(89 %)
27 diff
(97.2 %id)
W07463 lung .vd-u 830 to 1045 1 to 219       219/222
(98 %)
5 diff
(97.8 %id)
BQ879891 dorsal root ganglia .vd-u 836 to 1647 11 to 830   AAA   820/970
(84 %)
16 diff
(98.4 %id)
BE671715 pooled germ cell tumors .vd-u 851 to 1428 577 to 2       576/577
(99 %)
0 diff
(100 %id)
BG286712 bladder, transitional cell papilloma, cell line .vd-u 860 to 1584 1 to 719       719/1003
(71 %)
17 diff
(98.4 %id)
BE551725 pooled germ cell tumors .vd-u 875 to 1428 556 to 3       554/556
(99 %)
0 diff
(100 %id)
TI_157596256   .vd-u 883 to 1427 644 to 100   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 545/754
(72 %)
4 diff
(99.5 %id)
BU754582 placenta .vd-u 883 to 1427 563 to 19   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 545/547
(99 %)
4 diff
(99.3 %id)
BQ024784 placenta .vd-u 883 to 1426 561 to 19   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 543/545
(99 %)
5 diff
(99.1 %id)
R28404 placenta .vd-u 889 to 1130 1 to 252   fully sequenced,   252/252
(100 %)
6 diff
(97.7 %id)
CX755652 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .vd-u 890 to 1654 1 to 755     Submitted on the opposite strand 755/793
(95 %)
12 diff
(98.5 %id)
BQ025157 placenta .vd-u 893 to 1427 553 to 19   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 535/546
(97 %)
0 diff
(100 %id)
AW206461   .vd-u 900 to 1427 546 to 18   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 529/529
(100 %)
2 diff
(99.7 %id)
AW590506 pooled germ cell tumors .vd-u 900 to 1422 526 to 6       521/526
(99 %)
0 diff
(100 %id)
BG621366 placenta .vd-u 900 to 1534 1 to 634       634/634
(100 %)
2 diff
(99.7 %id)
AI885536 serous papillary carcinoma, high grade, 2pooled tumors, uterus .vd-u 933 to 1627 707 to 14   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 694/694
(100 %)
5 diff
(99.3 %id)
BQ575816 Chondrosarcoma Grade II, Left Pelvis .vd-u 954 to 1632 693 to 14   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 680/680
(100 %)
3 diff
(99.6 %id)
BM970064 lung .vd-u 956 to 1632 690 to 14   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 677/677
(100 %)
2 diff
(99.8 %id)
N69800 cochlea, ear .vd-u 962 to 1427 485 to 12   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 474/476
(99 %)
10 diff
(97.9 %id)
TI_151741305   .vd-u 962 to 1427 583 to 118   fully sequenced, AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 466/466
(100 %)
5 diff
(99.0 %id)
R93496 liver and spleen .vd-u 967 to 1419 12 to 467       456/467
(97 %)
6 diff
(98.8 %id)
BM829219 Ascites, stomach .vd-u 975 to 1553 1 to 579       579/579
(100 %)
2 diff
(99.7 %id)
R77151 placenta .vd-u 991 to 1120 1 to 130     Submitted on the opposite strand 130/130
(100 %)
0 diff
(100 %id)
BG938969 Bone, Hip .vd-u 1004 to 1593 17 to 606       590/613
(96 %)
1 diff
(99.9 %id)
CA337069 posterior rhombomeres 5-8 (4 pooled) .vd-u 1031 to 1656 1 to 626       626/635
(98 %)
3 diff
(99.6 %id)
BQ022600 placenta .vd-u 1066 to 1427 379 to 18   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 362/363
(99 %)
0 diff
(100 %id)
R25381 placenta .vd-u 1100 to 1427 341 to 1   fully sequenced,   341/341
(100 %)
15 diff
(95.7 %id)
TI_149275937   .vd-u 1105 to 1483 462 to 84       379/1099
(34 %)
0 diff
(100 %id)
BU676871 lung, Primary Lung Epithelial Cells .vd-u 1105 to 1483 392 to 14       379/397
(95 %)
0 diff
(100 %id)
CF456818 peripheral nervous system .vd-u 1114 to 1832 26 to 743   tiling clone,   718/744
(96 %)
2 diff
(99.8 %id)
AA443093 ovarian tumor, ovary .vd-u 1118 to 1631 514 to 1       514/514
(100 %)
4 diff
(99.3 %id)
CN345545 embryonic stem cells, cell lines H1, H7, andH9 .vd-u 1120 to 1712 1 to 592       592/592
(100 %)
1 diff
(99.9 %id)
BM790210 Ascites, stomach .vd-u 1120 to 1533 1 to 414       414/414
(100 %)
4 diff
(99.1 %id)
AI143063 heart .vd-u 1146 to 1633 488 to 1       488/488
(100 %)
2 diff
(99.6 %id)
CB999435 Pooled-Skin .vd-u 1155 to 1632 1 to 478       478/838
(57 %)
4 diff
(99.6 %id)
R77173 placenta .vd-u 1322 to 1630 310 to 1     Submitted on the opposite strand 310/310
(100 %)
1 diff
(99.7 %id)
R93497 liver and spleen .vd-u 2130 to 2489 365 to 1   tiling clone,   365/366
(99 %)
10 diff
(97.3 %id)
N81103 lung .vd-u 2165 to 2489 327 to 1   tiling clone,   327/341
(95 %)
3 diff
(99.2 %id)
BX460830 brain, fetal brain .ve-u 1 to 846 1 to 844   tiling clone,   844/844
(100 %)
5 diff
(99.5 %id)
BX451511 brain, fetal brain .ve-u 723 to 1645 1 to 911 exact tiling clone,   911/912
(99 %)
10 diff
(99.0 %id)
DB109744 thymus .vf-u 1 to 570 2 to 571   tiling clone, capped   570/570
(100 %)
0 diff
(100 %id)
AA332278 Embryo, 8 weeks .vf-u 429 to 600 1 to 173   tiling clone,   173/174
(99 %)
4 diff
(97.8 %id)
BQ219388 epithelioid carcinoma, Pancreas .vf-u 492 to 1124 680 to 43   tiling clone, AAA Submitted on the opposite strand 638/872
(73 %)
7 diff
(99.2 %id)
CV382646 colon .vf-u 624 to 1042 119 to 539       421/540
(77 %)
5 diff
(99.1 %id)
AL706891 human skeletal muscle .vf-u 652 to 1362 1 to 711 exact tiling clone,   711/711
(100 %)
2 diff
(99.8 %id)
AI631782 Kidney .vf-u 683 to 1110 428 to 1 exact     428/428
(100 %)
0 diff
(100 %id)
BX953769   .vg-u 1 to 563 1 to 563   tiling clone,   563/563
(100 %)
1 diff
(99.9 %id)
DA109492 cerebellum .vg-u 276 to 865 2 to 591 exact tiling clone, capped   590/590
(100 %)
0 diff
(100 %id)
BM852824 Ascites, stomach .vg-u 445 to 999 1 to 555   tiling clone,   555/555
(100 %)
3 diff
(99.5 %id)
BM793067 Ascites, stomach .vh 1 to 574 11 to 584 exact tiling clone,   574/584
(98 %)
6 diff
(99.0 %id)
AA704473 liver and spleen .vh 401 to 751 350 to 1   tiling clone,   350/350
(100 %)
1 diff
(99.8 %id)
AV731359 hypothalamus .vi-u 1 to 672 1 to 669 G28X tiling clone,   669/677
(98 %)
11 diff
(98.4 %id)
EB385760 eye, optic nerve .vi-u 53 to 683 1 to 631 exact tiling clone,   631/635
(99 %)
2 diff
(99.7 %id)
CN345550 embryonic stem cells, cell lines H1, H7, andH9 .vj 1 to 651 1 to 651   tiling clone,   651/651
(100 %)
0 diff
(100 %id)
DB276469 uterus .vj 20 to 559 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
DA062336 cerebellum .vk-u 1 to 569 2 to 571 V9X I11H L12I P13A I14Y ... tiling clone, capped   570/570
(100 %)
2 diff
(99.7 %id)
AA025574 heart .vl-u 1 to 498 504 to 3 Q22R I24N S25* tiling clone,   502/504
(99 %)
0 diff
(100 %id)
AV708940 adrenal gland Gene FGFR2, variant not shown         Suspected internal deletion, this clone was ignored    
BE147547 head_neck Gene FGFR2, variant not shown         Suspected internal deletion, this clone was ignored    
BE706533 head_neck Gene FGFR2, variant not shown         Suspected internal deletion, this clone was ignored    
BI030474 marrow Gene FGFR2, variant not shown              
CN287464 embryonic stem cells, cell lines H1, H7, andH9 Gene FGFR2, variant not shown              
DB313151 tongue, tumor tissue Gene FGFR2, variant not shown         This clone was ignored    
DA433729 tongue, tumor tissue Gene FGFR2, variant not shown       capped This clone was ignored    
EF057068   Gene FGFR2, variant not shown         This clone was ignored    
AV648849 corresponding non cancerous liver tissue Gene FGFR2, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
AV649140 corresponding non cancerous liver tissue Gene FGFR2, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
AV660627 corresponding non cancerous liver tissue Gene FGFR2, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
DB494575 hypothalamus Gene FGFR2, variant not shown         Suspected internal deletion, this clone was ignored    
DB500785 hypothalamus Gene FGFR2, variant not shown         Suspected internal deletion, this clone was ignored    
AV729513 hypothalamus Gene FGFR2, variant not shown         Suspected internal deletion, this clone was ignored    
AV729025 hypothalamus Gene FGFR2, variant not shown              
T83672 liver and spleen Gene FGFR2, variant not shown       fully sequenced,      
T83836 liver and spleen Gene FGFR2, variant not shown       fully sequenced,      
N75511 lung Gene FGFR2, variant not shown         Suspected internal deletion, this clone was ignored    
W05259 lung Gene FGFR2, variant not shown         Suspected internal deletion, this clone was ignored    
W87789 liver and spleen Gene FGFR2, variant not shown              
W87790 liver and spleen Gene FGFR2, variant not shown              
AI052334 liver and spleen Gene FGFR2, variant not shown              
AI052335 liver and spleen Gene FGFR2, variant not shown              
AI474284 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus Gene FGFR2, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
BI552680 brain, hippocampus Gene FGFR2, variant not shown       available from MGC, This clone was ignored    
CX782380 human embryonic stem cells Gene FGFR2, variant not shown       AAA This clone was ignored    
CX782454 human embryonic stem cells Gene FGFR2, variant not shown         This clone was ignored    
CB105111 Ascites, stomach Gene FGFR2, variant not shown              
BQ083222 Ascites, stomach Gene FGFR2, variant not shown         Suspected internal deletion, this clone was ignored    
DB234439 trachea Gene FGFR2, variant not shown       capped This clone was ignored    
DB350199 trachea Gene FGFR2, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va-u, .vb, .vc, .vd-u, .ve-u, .vf-u, .vg-u, .vh, .vi-u, .vj, .vk-u, .vl-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI